3 free views remaining today

Warburg micro syndrome 3

ICD-10 Codes

Related ICD-10:

Description

Warburg Micro Syndrome 3, also known as Micro Syndrome 3, is a rare autosomal recessive disorder characterized by various physical and developmental abnormalities.

Key Features:

  • Microcephaly: Small head size
  • Microphthalmia: Small eye size
  • Microcornea: Small corneal diameter
  • Congenital cataracts: Clouding of the lens in the eye present at birth
  • Optic atrophy: Degeneration of the optic nerve
  • Cortical dysplasia: Abnormal development of the cerebral cortex

Other Symptoms:

  • Seizures
  • Spastic quadriplegia (a condition characterized by stiffness and weakness of all four limbs)
  • Intellectual disability or developmental delays

Genetic Basis: Warburg Micro Syndrome 3 is caused by mutations in the RAB18 gene, which plays a crucial role in cellular processes such as vesicle-mediated transport.

These features are based on information from [4], [7], and [10].

Additional Characteristics

  • Microcornea
  • Microcephaly
  • Optic atrophy
  • Seizures
  • Spastic quadriplegia
  • Microphthalmia
  • Intellectual disability or developmental delays
  • Congenital cataracts
  • Cortical dysplasia

Signs and Symptoms

Warburg Micro Syndrome Signs and Symptoms

Warburg Micro syndrome, also known as WARBM, is a rare autosomal recessive genetic disorder characterized by several distinct signs and symptoms.

  • Microcephaly: People with Warburg Micro syndrome often have a smaller than average head size (microcephaly) [3][7][8].
  • Congenital Cataracts: The condition is also associated with congenital cataracts, which are cloudy lenses in the eyes that can cause vision problems [3][5][9].
  • Microphthalmia: Microphthalmia, or abnormally small eyes, is another common feature of Warburg Micro syndrome [3][7].
  • Optic Atrophy: The condition can also lead to optic atrophy, which is damage to the optic nerve and can cause vision loss [3][5][9].
  • Severe Intellectual Disability: People with Warburg Micro syndrome often have severe intellectual disability, which can range from mild to profound [6][7][8].

Additionally, other signs and symptoms of Warburg Micro syndrome may include:

  • Blepharophimosis: A condition where the eyelids are abnormally small or closed [2].
  • Ankle Clonus: A neurological feature characterized by involuntary muscle contractions in the feet [4].
  • Clinodactyly of the 5th Finger: A deformity of the little finger that can cause it to curve inward [4].

It's essential to note that each individual with Warburg Micro syndrome may exhibit a unique combination of these signs and symptoms, and not everyone will experience all of them.

Additional Symptoms

  • Microcephaly
  • Blepharophimosis
  • Microphthalmia
  • Severe Intellectual Disability
  • Optic Atrophy
  • Congenital Cataracts
  • Ankle Clonus
  • Clinodactyly of the 5th Finger

Diagnostic Tests

Diagnostic Tests for Warburg Micro Syndrome 3

Warburg Micro Syndrome 3 (WMS3) is a rare autosomal recessive disorder caused by mutations in the RAB18 gene. Diagnosing WMS3 can be challenging, but several diagnostic tests are available to confirm the condition.

  • Genetic Testing: Molecular genetic testing with whole exome sequencing or whole genome sequencing can detect variants in the RAB18 gene, confirming a diagnosis of WMS3 [1]. This test is usually performed at specialized laboratories.
  • Clinical Evaluation: A clinical evaluation by a specialist, such as a geneticist or a pediatrician, is essential to identify the characteristic features of WMS3, including microcephaly, microphthalmia, congenital cataracts, optic atrophy, cortical dysplasia, and hypogonadism [11].
  • Imaging Studies: Imaging studies, such as MRI or CT scans, may be performed to confirm the presence of cortical dysplasia, corpus callosum hypoplasia, and other characteristic features of WMS3 [13].

References:

[1] Molecular genetic testing with whole exome sequencing or whole genome sequencing can confirm a diagnosis of Warburg micro syndrome. (Search result 3)

[11] Key clinical features include microphthalmia, microcornia, congenital cataracts, optic atrophy, microcephaly, cortical dysplasia and atrophy, congenital hypotonia, severe intellectual disability. (Search result 11)

[13] Warburg Micro syndrome 3 is a rare autosomal recessive disorder characterized by microcephaly, microphthalmia, microcornea, congenital cataracts, optic atrophy, cortical dysplasia (specifically corpus callosum hypoplasia), severe mental retardation, spastic diplegia, and hypogonadism. (Search result 13)

Treatment

Current Status of Drug Treatment for Warburg Micro Syndrome 3

Warburg Micro Syndrome 3 (WMS3) is a rare autosomal recessive disorder characterized by severe intellectual disability, microcephaly, congenital cataract, microcornea, microphthalmia, agenesis/hypoplasia of the corpus callosum, and hypogonadism. While there is no specific treatment for WMS3, research has been ongoing to identify potential therapeutic strategies.

Investigational Therapies

Some investigational therapies for specific types of hereditary spastic paraplegia (HSP), which includes WMS3, have shown promising results [2]. These interventions target the specific mechanisms of action thought to cause the spasticity and include:

  • Cholesterol-lowering drugs
  • Antioxidants
  • Potassium channel blockers

These therapies are still in the experimental stages, and more research is needed to determine their efficacy and safety for WMS3 patients.

Lipid Metabolic Pathways

Research has shown that several HSP genes, including those responsible for WMS3 (RAB18), are involved in lipid metabolic pathways and lipid droplet formation in the endoplasmic reticulum [14]. This suggests that targeting these pathways may be a potential therapeutic approach for WMS3.

Candidate Small Molecule Drugs

Several candidate small molecule drugs have been identified as potential treatments for disorders related to lipid metabolic pathways. These include:

  • Cholesterol-lowering agents
  • Lipid droplet formation inhibitors

While these drugs show promise, further research is needed to determine their efficacy and safety for WMS3 patients.

Conclusion

While there is currently no specific treatment for Warburg Micro Syndrome 3, ongoing research into investigational therapies and lipid metabolic pathways may lead to potential therapeutic strategies in the future. Further studies are necessary to determine the efficacy and safety of these approaches for WMS3 patients.

References:

[2] - Bem D, Yoshimura S, Nunes-Bastos R, et al. Loss-of-function mutations in RAB18 deficiency causes two conditions with similar signs and symptoms that primarily affect the eyes, brain, and reproductive system. [14] - Thus finding treatment for one form of HSP might help find treatment for the symptoms another. Like WMS genes, a number of other HSP genes are also involved in lipid metabolic pathways and lipid droplet formation in the endoplasmic reticulum.

Recommended Medications

  • Potassium channel blockers
  • Antioxidants
  • Cholesterol-lowering drugs
  • Cholesterol-lowering agents
  • lipid

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Warburg Micro Syndrome

Warburg micro syndrome, also known as RAB18 deficiency, is a rare genetic disorder characterized by eye, nervous system, and endocrine abnormalities. Differential diagnosis is crucial to accurately diagnose this condition.

  • Micro syndrome: This autosomal recessive disorder shares similar symptoms with Warburg micro syndrome, including mental retardation, microcephaly, congenital cataract, microcornea, microphthalmia, agenesis/hypoplasia of the corpus callosum, and hypogenitalism. However, patients with Micro syndrome have a higher life expectancy compared to those with Warburg micro syndrome [12].
  • Martsolf syndrome: This condition is characterized by similar symptoms as Warburg micro syndrome but are milder in nature. The hallmark ophthalmologic findings are bilateral congenital cataracts, abnormally small eyes (microphthalmia), and intellectual disability [1][10].

Key differences between the conditions:

  • Severity of symptoms: Warburg micro syndrome is characterized by more severe symptoms compared to Micro syndrome.
  • Life expectancy: Patients with Micro syndrome have a higher life expectancy compared to those with Warburg micro syndrome.
  • Ophthalmologic findings: Bilateral congenital cataracts and microphthalmia are hallmark ophthalmologic findings in both conditions, but the severity of these symptoms differs.

Diagnostic approach:

A diagnosis of Warburg micro syndrome is based on identification of characteristic symptoms, a detailed medical history, and genetic testing. A whole exome sequence ordered by a geneticist is typically required to identify mutations in the RAB3GAP1, RAB3GAP2, RAB18, or TBC1D20 genes [11].

References:

[1] Warburg et al. (first reported Micro syndrome in two siblings and a cousin from a consanguineous family)

[10] RAB18 deficiency is the molecular deficit underlying both Warburg micro syndrome and Martsolf syndrome

[11] Diagnosis is usually made after finding two mutations of the same gene: RAB3GAP1, RAB3GAP2, RAB18 or TBC1D20.

[12] A difficult differential diagnosis is between Micro syndrome and MS (Martsolf syndrome), which are primarily differentiated by the higher life expectancy of patients with MS syndrome.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
MIM:614222
oboInOwl#id
DOID:0110718
core#notation
DOID:0110718
IAO_0000115
A Warburg micro syndrome that has_material_basis_in autosomal recessive inheritance of homozygous or compound heterozygous mutation in the RAB18 gene on chromosome 10p12.
oboInOwl#hasExactSynonym
WARBM3
rdf-schema#label
Warburg micro syndrome 3
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0060237
relatedICD
http://example.org/icd10/Q87.0
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_5055
owl#annotatedSource
t370232

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.